Hong Kong/Macau, China

Galderma is the world's largest independent global dermatology company, created in 1981 and are now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetic solutions and consumer care products. We partner with healthcare practitioners around the world to meet the skin health needs of people throughout their lifetime. We are leader in research and development of scientifically-defined and medically-proven solutions for the skin.
 

Galderma Hong Kong Limited was established in 2000 as part of the global organization, Galderma S.A.

 

OUR PURPOSE

ADVANCING DERMATOLOGY FOR EVERY SKIN STORY

We know that everyone’s skin is unique. That’s why Galderma offers an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market.
Our brands hold leading market positions in their respective product categories, and our products and services are supported by science. They enable us to meet patients’ diverse and evolving needs and provide superior, lasting outcomes through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

 

OUR BUSINESS UNITS & BRANDS

DERMATOLOGICAL SKINCARE

The Dermatological Skincare market segment comprises branded health and beauty products – which are backed by science. Galderma's Cetaphil® and Alastin® brands offer science-based, dermatologist-recommended solutions that hold leading market positions.

• Cetaphil 舒特膚 https://cetaphil.com.hk
 

THERAPEUTIC DERMATOLOGY

The Therapeutic Dermatology market segment encompasses prescription treatments that target moderate to severe skin conditions, from acne to skin cancer.

• Acne Products: Aklief, Differin; Epiduo; Epiduo forte; Tetralysal
• Rosacea Products: Soolantra; Mirvaso; Rozex
• OTC Products:
   · Benzac 克痘靈 https://www.instagram.com/benzac_hk
   · Loceryl 羅霉樂 https://www.facebook.com/locerylhk
• Other Products: Clobex; Desowen; Silkis; Triluma
 

INJECTABLE AESTHETICS

The Injectable Aesthetics market segment is large, attractive and has strong growth fundamentals. With our presence in neuromodulators, fillers and biostimulators, Galderma is ideally positioned to capitalize on this growth.

• Dysport® https://galdermaaesthetics.com.hk/dysport
• relfydess® https://galdermaaesthetics.com.hk/product/relfydess
• Restylane® https://galdermaaesthetics.com.hk/restylane
• Restylane® Skinboosters™ https://galdermaaesthetics.com.hk/skinboosters
• Sculptra® https://galdermaaesthetics.com.hk/sculptra